Gampenrieder, Simon Peter
Rinnerthaler, Gabriel
Tinchon, Christoph
Petzer, Andreas
Balic, Marija
Heibl, Sonja
Schmitt, Clemens
Zabernigg, August Felix
Egle, Daniel
Sandholzer, Margit
Singer, Christian Fridolin
Roitner, Florian
Hager, Christopher
Andel, Johannes
Hubalek, Michael
Knauer, Michael
Greil, Richard http://orcid.org/0000-0002-4462-3694
Funding for this research was provided by:
roche
daiichi-sankyo
pfizer
astrazeneca
Article History
Received: 20 July 2021
Accepted: 28 November 2021
First Online: 14 December 2021
Declarations
:
: The registry was approved by the Ethics Committee of the province Salzburg (IRB number: 415-E/1836). All patients provided written informed consent or died before data entry.
: Not applicable.
: SPG received honoraria from Roche, Daiichi Sankyo, Seagen, Novartis, BMS, AstraZeneca, Eli Lilly and MSD, travel support from Roche, Amgen, Novartis, Pfizer, Daiichi Sankyo, and a research grant from Roche. GR received honoraria from Roche, Novartis, Amgen, Pfizer, Daiichi Sankyo, MSD, Eli Lilly, and Bristol-Myers Squibb, declared speaker bureau/expert testimony for Amgen, Astra Zeneca, Novartis, Bristol-Myers Squibb, Roche, Pfizer, and Eli Lilly, and a research grant from Roche. AP received honoraria from Pfizer, Roche, Novartis, Celgene-BMS, Celgene, Eli Lilly, AstraZeneca, Saegen, Daiichi Sankyo, and Gilead, and travel support from Roche, and Pfizer. MB received honoraria from Amgen, AstraZeneca, Bayer, Celgene, Pfizer, Eli Lilly, Novartis, Roche, MSD, Samsung and Pierre Fabre, declared speaker bureau/expert testimony for Amgen, AstraZeneca, Bayer, Celgene, Pfizer, Eli Lilly, Novartis, Roche, MSD, Samsung and Pierre Fabre, received research grants (institution) from Amgen, Celgene, Eli Lilly, Novartis and Pfizer, and travel support from Amgen, AstraZeneca, Bayer, Celgene, Pfizer, Eli Lilly, Novartis, Roche, MSD, Samsung and Pierre Fabre. SH received honoraria from Celgene, Novartis, AOP Orphan, Takeda, and Roche, travel support from Roche, Sanofi, AbbVie, and Pfizer, and research grants (institution) from Celgene, and AOP Orphan. AFZ received honoraria from Roche, BMS, Lilly, Astra Zeneca, Takeda, and MSD, and travel support from Roche, Takeda, BMS, and Lilly. DE received honoraria from Roche, Pfizer, Novartis, AstraZeneca, Pierre Fabre, Lilly, and MSD, and travel support from Roche, Pfizer, Novartis, AstraZeneca, Pierre Fabre, Lilly, and MSD. MS received honoraria from Novartis, Lilly, Roche, AstraZeneca, Pfizer, Myriad, Pierre Fabre, and Amgen, and travel support from Pfizer, Roche, Celgene, Lilly, Novartis, and Merck. CFS received honoraria from Amgen, Roche, Novartis, and AstraZeneca, travel support from Pfizer, AstraZeneca, and Tesaro, and research grants from Amgen, Roche, and AstraZeneca. FR received honoraria from Pfizer, Roche, Daiichi Sankyo, and Pierre Fabre (institution), and travel support from Pfizer, Eli Lilly, Roche, Pierre Fabre. MH received honoraria from Amgen, Roche, Lilly, and Pfizer, and travel support from Roche, Pfizer. MK received honoraria travel support from Roche, and a research grant (institution) from Agendia. RG received honoraria from Celgene, Roche, Merck, Takeda, AstraZeneca, Novartis, Amgen, BMS, MSD, Sandoz, AbbVie, Gilead, and Daiichi Sankyo, travel support from Roche, Amgen, Janssen, Astra Zeneca, Novartis, MSD, Celgene, Gilead, BMS, AbbVie, and Daiichi Sankyo, and research grants from Celgene, Roche, Merck, Takeda, AstraZeneca, Novartis, Amgen, BMS, MSD, Sandoz, Abbvie, Gilead, and Daiichi Sankyo. CT, CS, CH, and JA declare that they have no competing interests.